




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Heart Failure and Cardiomyopathies</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=f726f673-7e11-4292-84ae-69b198c58cf7</link>
        <description>Clinical Topic Feed: Heart Failure and Cardiomyopathies</description>
        <language>en</language>

        

                <item>
                    <title>LCZ in nHCM: Sacubitril/Valsartan Promotes Cardiac Remodeling, But Not Functional Capacity, in Nonobstructive HCM</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/08/25/13/59/LCZ-in-nHCM</link>                    <description>Functional capacity as measured by peak oxygen uptake (pVO2) was not improved with sacubitril/valsartan (LCZ696) in patients with nonobstructive hypertrophic cardiomyopathy (nHCM), while there was favorable cardiac structural remodeling, according to research published Aug. 19 in JACC: Heart Failure.</description>
                    <pubdate>1787761500000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: Is Lower Cardiorespiratory Fitness Associated with Later-Life Dementia? </title>
<link>/Latest-in-Cardiology/Articles/2026/08/26/13/33/eagles-eye-view-26aug2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle&#226;€&#175;looks at the relationship between lower cardiorespiratory fitness (CRF) and higher coronary artery calcium scores (CAC) and later-life dementia.</description>
                    <pubdate>1787751300000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Clinical Practice Algorithm For the Follow-Up of Unrepaired and Repaired Patent Ductus Arteriosus</title>
<link>/Latest-in-Cardiology/Articles/2022/10/31/13/02/Clinical-Practice-Algorithm-For-the-Follow-Up-of-Unrepaired-and-Repaired-PDA</link>                    <description>Isolated patent ductus arteriosus (PDA) is a relatively common defect, accounting for 5-10% of congenital heart defects (excluding premature infants).1 Given the increased use of echocardiography, incidental detection of asymptomatic silent PDAs is on the rise.</description>
                    <pubdate>1787745300000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACCEL Lite: Umbrella: Cardioprotection During Treatment</title>
<link>/Latest-in-Cardiology/Articles/2026/08/24/16/23/accel-lite-24aug2026</link>                    <description>In this interview, Dipti Itchhaporia MD, MACC and Ana Barac, MD, PhD, FACC discuss Umbrella: Cardioprotection During Treatment.</description>
                    <pubdate>1787674980000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>What is the Prognostic Value of Stress Perfusion CMR in Patients With Suspected CAD?</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/08/25/13/59/What-is-the-Prognostic-Value-of-Stress-Perfusion-CMR</link>                    <description>The absence of ischemia in patients evaluated using vasodilator stress perfusion cardiac magnetic resonance (CMR) was associated with low risk of angiographically verified high-risk coronary artery disease (CAD) and adverse cardiovascular events, according to a recent study published in JACC: Cardiovascular Imaging.</description>
                    <pubdate>1787673780000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>OCEAN-Mitral Registry: M-TEER Feasible, Safe, Effective in Patients With Very Severe LV Dysfunction</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/08/25/13/59/OCEAN-Mitral-Registry</link>                    <description>Among patients with ventricular functional mitral regurgitation (MR) and very severe left ventricular (LV) dysfunction (LVEF &amp;lt;20%), mitral transcatheter edge-to-edge repair (M-TEER) was found to be feasible and associated with meaningful symptomatic improvement, according to findings published Aug. 17 in JACC: Advances.</description>
                    <pubdate>1787666460000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>TARTAN-HF: NT-proBNP Screening Identifies Undiagnosed HF Among Patients With Diabetes</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/08/18/18/12/TARTAN-HF</link>                    <description>A heart failure (HF) screening strategy focused on NT-proBNP identified a large proportion of patients with diabetes who had previously unrecognized but symptomatic HF, according to research published Aug. 19 in JACC.</description>
                    <pubdate>1787151000000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Beyond BMI: Body Composition Patterns Emerge in HF</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/08/18/18/12/Beyond-BMI</link>                    <description>Study participants with heart failure (HF), compared with controls, had had more visceral adipose tissue (VAT), more adverse muscle changes and weaker grip strength, according to research published Aug. 6 in JACC: Heart Failure.</description>
                    <pubdate>1787151000000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Vutrisiran Associated With Favorable Changes in Cardiac Parameters, Amyloid Burden</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/08/18/18/12/Vutrisiran-Associated</link>                    <description>In patients with transthyretin amyloid cardiomyopathy (ATTR-CM), treatment with vutrisiran is associated with favorable changes in cardiovascular magnetic resonance (CMR) parameters related to cardiac structure, function and amyloid burden, according to a retrospective post hoc analysis of the HELIOS-B trial published Aug. 12 in JAMA Cardiology.</description>
                    <pubdate>1787077860000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>PAP Predicts 2-Year HF Hospitalization Risk in Chronic HF</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/08/17/20/17/PAP-Predicts</link>                    <description>Baseline pulmonary artery pressure (PAP) and six-month changes in PAP helped predict heart failure hospitalization (HFH) within two years in patients with chronic heart failure (HF), according to research published Aug. 6 in JACC: Heart Failure. The findings add to evidence linking PAP with HFH risk and mortality.</description>
                    <pubdate>1787064720000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>